Key facts
- This page summarizes Jason O'Byrne's Form 4 filing for Vir Biotechnology, Inc. (VIR).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 23 Mar 2026, 15:49.
Jason O'Byrne - 20 Mar 2026 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)
- Reporting relationship
- EVP & Chief Financial Officer
- Issuer ticker
- VIR
- Reported as of
- 20 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Mar 2026, 15:49:52 UTC
- Prior SEC filing
- 26 Feb 2026
- Next SEC filing
- 13 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Vanina de Verneuil, Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jason O'Byrne filed Form 4 for Vir Biotechnology, Inc. (VIR) on 23 Mar 2026.
Change
- Previous filing in this sequence was filed on 26 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001871145
Primary reporting owner
O'Byrne Jason
- Relationship
- EVP & Chief Financial Officer
- Address
- C/O VIR BIOTECHNOLOGY, INC., 1800 OWENS STREET, SUITE 900, SAN FRANCISCO
- Signature
- /s/ Vanina de Verneuil, Attorney-In-Fact
- Signature date
- 23 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VIR
transaction
Common Stock
Other
- Transaction value
- Shares
- -2,500
- Change %
- -1.5%
- Price
- $0.000000*
- Shares after
- 160,115
- Date
- 20 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
VIR
transaction
Common Stock
Other
- Transaction value
- Shares
- +2,500
- Change %
- Price
- $0.000000*
- Shares after
- 2,500
- Date
- 20 Mar 2026
- Ownership
- See Footnote
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Transfer without consideration for estate planning purposes.
Footnote F2
The shares are held in the name of the O'Byrne Family Trust, of which the Reporting Person and his spouse are Trustees.